BSX Q2 2018 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$103B

Q2 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$2.5B+10.3% YoY

Gross Profit

$1.6B65.5% margin

Operating Income

$447M18.0% margin

Net Income

$555M22.3% margin

EPS (Diluted)

$0.40

QoQ Revenue Growth

+4.7%

Cash Flow

Operating Cash Flow

-$403M

Free Cash Flow

-$486M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$19.6B

Total Liabilities

$11.9B

Stockholders' Equity

$7.7B

Cash & Equivalents

$208M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.5B	$2.3B	+10.3%
Gross Profit	$1.6B	$1.5B	+11.0%
Operating Income	$447M	$395M	+13.2%
Net Income	$555M	$146M	+280.1%

Revenue Segments

Cardiovascular

$965M56%

MedSurg

$751M44%

Geographic Segments

UNITED STATES

$1.4B56%

Non-US

$1.1B44%